Medicare Enrolled

Dr. Suruchi Kaul, M.D.

Nephrology · Norwood, MA
Low-engagement
101 ACCESS RD, Norwood, MA 02062
7817626944
In practice since 2007 (18 years)
NPI: 1962683847 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kaul from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaul? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kaul

Dr. Suruchi Kaul is a nephrology specialist in Norwood, MA, with 18 years of NPI registration.

Between the years covered by Open Payments, Dr. Kaul received a total of $1,471 from 24 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kaul is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice $1,471 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$1,471
Total received (2021-2024)
Avg $368/year across 4 years
Top 32% in MA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,471 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$655
2023
$548
2022
$227
2021
$40

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$125
Lilly USA, LLC
$71
SHIELD THERAPEUTICS INC
$59
PFIZER INC.
$54
ABBVIE INC.
$43
Medtronic, Inc.
$41
GlaxoSmithKline, LLC.
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Novo Nordisk Inc
$28
Janssen Pharmaceuticals, Inc
$28
Astellas Pharma US Inc
$26
Novartis Pharmaceuticals Corporation
$24
CALLIDITAS THERAPEUTICS US INC.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
Lundbeck LLC
$17
Top 3 companies account for 39.0% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$276
AstraZeneca Pharmaceuticals LP
$199
Bayer Healthcare Pharmaceuticals Inc.
$102
Lilly USA, LLC
$98
PFIZER INC.
$70
SHIELD THERAPEUTICS INC
$59
Amgen Inc.
$53
Astellas Pharma US Inc
$53
Janssen Pharmaceuticals, Inc
$52
GRT US Holding, Inc.
$49
Novo Nordisk Inc
$48
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$48
CALLIDITAS THERAPEUTICS US INC.
$43
Medtronic, Inc.
$41
Shield Therapeutics Inc
$38
Abbott Laboratories
$35
Sumitomo Pharma America, Inc.
$34
GlaxoSmithKline, LLC.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Amarin Pharma Inc.
$28
Novartis Pharmaceuticals Corporation
$24
Amryt Pharma Holdings Ltd
$21
Lundbeck LLC
$17
E.R. Squibb & Sons, L.L.C.
$17
Top 3 companies account for 39.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AREXVY · CREON · ELIQUIS · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GEMTESA · JARDIANCE · Kerendia · LEQVIO · LOKELMA · MINIMED 780G · MOUNJARO · MYCAPSSA · NURTEC ODT · Otezla · Ozempic · PREVNAR 20 · Qutenza · REXULTI · Repatha · SYNTHROID · TARPEYO · UBRELVY · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nephrology specialist in Norwood?
Compare nephrologists in the Norwood area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
185
Per 100K population
25.5
County median income
$126,497
Nearest hospital
NORWOOD HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kaul is a nephrology specialist, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Kaul receive payments from pharmaceutical companies?
Yes. Dr. Kaul received a total of $1,471 from 24 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kaul) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Norwood
Browse nephrologists in Norwood ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in MA
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in MA
Which MA nephrologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer Healthcare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer Healthcare Pharmaceuticals Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →